LawrencePeterLeichmanMD

Oncology • Palm Springs, CA

Physician

Join to view full profile

Dr. Leichman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leichman's full profile

Already have an account?

Office
1180 N Indian Canyon Dr
Ste E218
Palm Springs, CA 92262
Phone+1 760-416-4860

Fax+1 760-416-4903

Education & Training

Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 1977 - 1979
Wayne State University School of MedicineResidency, Internal Medicine, 1975 - 1977
Detroit Medical Center/Wayne State UniversityInternship, Internal Medicine, 1973 - 1974
Wayne State University School of MedicineClass of 1973

Certifications & Licensure

CA State Medical License 1987 - 2025
NY State Medical License 1997 - 2025
MI State Medical License Active through 1989
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma Start of enrollment: 1994 Aug 01
Completed
Phase 2
Altretamine and Etoposide in Treating Patients With HIV-Related Cancer Start of enrollment: 1996 Jul 01
Completed
Phase 1
Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma Start of enrollment: 1996 Nov 01
Completed
Phase 3
Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 1999 Jul 01
Completed
Phase 2
Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer Start of enrollment: 2000 Jan 01
Completed
Phase 1
Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status Start of enrollment: 2009 May 01
Completed
Phase 2
Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec Start of enrollment: 2010 Apr 01
Completed
Phase 2
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer Start of enrollment: 2011 May 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

1499 citations
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus
Arnold Herskovic, Karen L. Martz, Muhyi Al-Sarraf, Lawrence Leichman, Jeffrey Brindle
The New England Journal of Medicine. 1992-06-11
408 citations
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluor...
Ralf Metzger, Cynthia G. Leichman, Kathleen D. Danenberg, Peter V. Danenberg, Heinz-Josef Lenz
Journal of Clinical Oncology. 1998-01-01
199 citations
High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-...
Ralf Metzger, K. Danenberg, C. G. Leichman, Dennis Salonga, E L Schwartz
Clinical Cancer Research. 1998-10-01

Journal Articles

Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction and Gastric Adenocarcinoma
Lawrence Leichman, Jason K Sicklick, Shumei Kato, Kaitlyn Kelly, Scott M Lippman, Clinical Cancer Research

Grant Support

Response Determinants In Esophageal And Gastric CancersNational Cancer Institute1994–1995
Thymidylate Synthase Quantitation In Human Colon CancerNational Cancer Institute1993–1995
Response Determinants In Egophageal And Gastric CancersNational Cancer Institute1993